Vibrant Therapeutics
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$64.35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vibrant Therapeutics is a biotechnology company that develops intelligent, logic-gated therapeutics designed to selectively activate in the desired disease microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vibrant Therapeutics Comparables
Compare Vibrant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 69% | |
| Takeda | 67% | |
| Ironwood Pharmaceuticals | 64% |
Vibrant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Series A Extension | Aug 25, 2025 | ||||
| Series A | Aug 25, 2025 | ||||
| Series A | Jul 19, 2023 |
Vibrant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| First Principle Venture Limited | Series B |
| Advantage Capital | Series A |
| Northern Light Venture Capital | Series B |
| Bayland Capital | Series B |
| Trinity Innovation Fund | Series A |
| Pfizer Ventures | Series B |
| HongShan Capital Group (HSG) | Series A, Series A Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 292% MoM, from 275 to 1.1K.
- Jan 15, 2026
Han Lee appointed co-chief executive officer alongside founder Larry Wang.
Vibrant Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vibrant Therapeutics's valuation, stock price, and market status.
Is Vibrant Therapeutics a public or private company?
Vibrant Therapeutics is a private company.
What is the current stock price of Vibrant Therapeutics?
Vibrant Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Vibrant Therapeutics worth (valuation)?
Valuation information for Vibrant Therapeutics is not publicly available.
Can I buy Vibrant Therapeutics stock?
Vibrant Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Vibrant Therapeutics's last funding round?
Vibrant Therapeutics's most recent funding round was Early Funding on January 12, 2026.
Who are the main investors in Vibrant Therapeutics?
Key investors in Vibrant Therapeutics include Advantage Capital, Trinity Innovation Fund, Pfizer Ventures, Apricot Capital.
Will Vibrant Therapeutics IPO soon?
No public IPO plans have been announced for Vibrant Therapeutics.
How can I track Vibrant Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vibrant Therapeutics's secondary market activity and sign up for updates.